therapeutic action: Molecular diagnosis enabling early treatment initiation

Multicenter performance evaluation of the “quanty TOXO (RH region)” kit (Clonit) for molecular diagnosis of toxoplasmosis

Researchers from seven French hospitals tested a commercial DNA test kit called “quanty TOXO” that detects Toxoplasma gondii, a parasite causing serious infections in pregnant women and people with weakened immune systems. The kit performed well overall, correctly identifying infection in nearly 95% of positive cases and showing no false positives. However, the test sometimes missed infections when parasite levels were very low, suggesting doctors should run tests twice to increase detection chances.

Read More »
Scroll to Top